Skip to main content

Clinical trial AMC303-01

A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin

Organ Multiple
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 1/1b
Academic trial Non
Sponsor Amcure GmbH
EudraCT Identifier 2016-001358-16
Inclusion criteria any line RECIST 1.1
Last update